Category: AI in oncology care

Kapa3 announces collaboration with SimasiaAI for the development of the Health Navigator “Myrto” (Myrto AI Assistant)

The Kapa3 – Cancer Guidance Center announces its collaboration with SimasiaAI, for the co-development of the Health Navigator “Myrto” (Myrto AI Assistant), an artificial intelligence (AI chatbot) designed to enhance digital cancer support for patients with cancer and their families through immediate, reliable, and personalized information.

This initiative is part of Kapa3’s strategic focus on leveraging innovative digital tools to improve access to information, strengthen guidance, and reduce the digital gap often faced by vulnerable groups in the healthcare sector.

The Health Navigator “Myrto” is not just an information tool, but a new form of social artificial intelligence in cancer care support in Greece. It is designed to transform digital information into a more human, accessible, and meaningful experience, allowing users to interact, receive guidance, and access support tailored to their needs.

Through its dual role as a “Patient Empowerment e-Navigator”, the system will function both as a Patient Advocate—providing guidance on patient rights, benefits, and access to healthcare and social services—and as a Health Navigator, offering reliable information to support better understanding and self-management of health-related issues.

At the same time, the Health Navigator “Myrto” aims to enhance health literacy, support the psychosocial dimension of the disease, and highlight available community resources, contributing to the reduction of inequalities in access to information.

Kapa3, with its long-standing experience in guiding and supporting cancer patients, continues to invest in initiatives that promote equal access to information and digital empowerment, utilizing technology with a strong social and human-centered approach.

The collaboration between Kapa3 and SimasiaAI leads to the development and integration of the Health Navigator “Myrto” into Kapa3’s platform, highlighting the importance of cooperation between social organizations and technology providers in creating innovative digital support tools for cancer patients. Through this initiative, the goal is to meaningfully empower patients, support healthcare professionals, and advance more human-centered digital services.

The development of the Health Navigator “Myrto” marks an important step toward a new model of digital care, where artificial intelligence complements human support, enhancing the quality of life of patients and their families.

The Founding Sponsor of the “Myrto”Health Navigator is the TIMA Foundation.

Our Press Release text here: PRESS RELEASE SIMASIA AI

Text: Ifiyenia Anastasiou for Kapa3

Kapa3 at the “Facing the Challenge of Artificial Intelligence” Event

On March 11, 2026, Kapa3 co-founder Evangeli Bista and the organization’s collaborator, Christos Frantzidis, senior lecturer at the School of Computer Science, University of Lincoln, attended with keen interest the event “Facing the Challenge of Artificial Intelligence”, organized by diaNEOsis at the Stavros Niarchos Foundation Cultural Center Lighthouse, marking 10 years of the organization’s work.

The event highlighted, through presentations and discussions, key topics regarding Artificial Intelligence (AI), including: what AI is and the concerns it raises, social impacts and inequalities it may create, ethical and responsible use, effects on work and productivity, and the challenges in legislation and technology regulation.

As Evangeli Bista noted on her social media, AI remains a field full of questions:

  • What exactly is Artificial Intelligence?
  • What concerns are emerging around it?

“Technology without thought can reinforce the greatest inequalities,” she emphasized, adding that the conversation on ethical and scientifically informed access to technology remains open. The event offered the chance to see “the next day… through the eyes of those who pioneered it,” such as Joseph Sifakis (Turing Award 2007) and Christos Papadimitriou.

Kapa3’s participation focused on observing, absorbing knowledge, and supporting dialogue around the challenges and opportunities of AI, with particular attention to the social dimension and the inequalities it may create.

By attending this event, Kapa3 continues to demonstrate its commitment to technological developments, the importance of informed and responsible discussion, and understanding the social and ethical implications of Artificial Intelligence.

Kapa3 Participation in the 3rd “Mapping the Unknown in Oncology” Conference

Kapa3 actively participated in the conference “Mapping the Unknown in Oncology – From Hospitals to Homes, mapping the future of oncology care”, organized for its third year by the Medical Society for Research and Education under the auspices of HeSMO (Hellenic Society of Medical Oncologists) and the Hellenic Cancer Society, held on February 27–28, 2026 at the Golden Age Hotel in Athens.

During the events on Saturday, February 28, Ms. Evangelí Bista, Head of Operations and Development at the Kapa3 Cancer Patient Guidance Center, took part in the panel titled “e-Health Tools and Educational Platforms: New Paths for Doctors and Patients.” The panel was moderated by Ms. Z. Saridaki and included panelists G. Koukourakis, S. Peroukidis, F. Tyligadas, and Ch. Christodoulou.

In her presentation, titled “Digital Patient Education: The Patient as an Active Partner,” Ms. Bista highlighted the importance of digital transformation in healthcare, which shifts care from episodic to continuous support, moving healthcare from hospitals into patients’ daily lives and empowering patients to become active participants in managing their health.

In this context, Kapa3 announced that for 2026 it will be the only civil society organization fully integrating AI, cybersecurity, and high-performance computing into its processes and services, implementing:

  • An AI-powered digital assistant (chatbot) for immediate patient guidance and support

  • A voice-command system for website accessibility and text-to-speech conversion

  • Service redesign, simplifying processes and reducing bureaucracy

  • An AI-based recommendation system with usage data analysis to personalize services

Special emphasis was placed on patient navigation, as oncology patients need guidance: where to go, what they are entitled to, when to be concerned, and when to wait. Kapa3 addresses this gap, providing not just information but meaningful, personalized guidance within the healthcare system.

The goal is not to add another service but to unite existing services. The next evolution of this model is Myrto, the digital assistant that serves as a reference point, translating knowledge into daily action.

Because the future of oncology is not only personalized treatment but also personalized understanding.

Kapa3’s participation underscores the organization’s commitment to innovation, collaboration, and ethics, demonstrating how technology can significantly enhance the experience and care of oncology patients.

 

 

Artificial Intelligence in Medicine: Why Horizontal Skills Are More Critical Than Ever

Artificial intelligence is rapidly transforming clinical decision-making, healthcare professional education, and overall care delivery. Yet a recent international review highlights a crucial point: as AI tools become more integral, horizontal skills (soft skills) such as empathy, communication, critical thinking, and ethical judgment are more important than ever.

These competencies enable healthcare professionals to interpret algorithmic outputs, maintain patient trust, ensure safe care, and integrate technology responsibly into clinical practice. Understanding and fostering these skills is essential for building a healthcare workforce that remains human-centered in an AI-driven era.

The review is authored solely by Effie Simou, Associate Professor of Communication and Media in Public Health at the University of West Attica, and examines the role of horizontal skills in the modern, technology-enhanced healthcare environment. By synthesizing international literature, it analyzes how professional responsibility, teamwork, cultural sensitivity, and ethical judgment impact care quality and safety in an era where artificial intelligence plays an ever more active role.

A “Skills Ecosystem” Rather Than a List of Competencies

The review does not treat these skills as isolated capabilities but as an interdependent ecosystem. Communication strengthens trust, empathy improves patient adherence, critical thinking acts as a counterbalance to uncritical acceptance of algorithmic recommendations, while professionalism and ethical vigilance ensure accountability.

The key argument is clear: technological progress does not make horizontal skills less important—it makes them essential. In an environment where algorithms support diagnosis, predict risks, or suggest treatment strategies, healthcare professionals are called upon to interpret, evaluate, and ultimately take responsibility for the decisions made.

Human Judgment Is Not Replaced. It Is Strengthened—and Tested.

Artificial Intelligence in Medicine and the Risks of Uncritical Trust in Technology

Particular emphasis is placed on the risks arising from excessive trust in AI systems. The so-called “automation bias” can lead to reduced critical vigilance, while the complexity of algorithms may hinder understanding of how their recommendations are generated.

Large language models and AI tools can also produce inaccurate or incomplete information persuasively. In a clinical setting, such misleading certainty can have serious consequences.

In this context, artificial intelligence in medicine cannot function autonomously; it requires active and critical human oversight. Critical thinking, transparency, and clear responsibility allocation become absolutely necessary. The final decision regarding patient care cannot be delegated to an algorithm. Responsibility remains human—a fundamental principle for the ethics of medical practice.

The Patient Relationship Dimension

Technology can enhance accuracy, accelerate processes, and support the management of large data volumes. However, it cannot replace the therapeutic relationship. Trust, clear communication, active listening, and recognition of patients’ emotional needs are elements that cannot be coded.

Especially in fields like oncology, where decisions are complex and the emotional burden high, the quality of communication can significantly influence treatment adherence, understanding of options, and overall care experience.

The review emphasizes that human presence is not supplementary to technology—it is the axis around which it must be organized.

Toward a Balanced Human–Algorithm Coexistence

The study’s conclusion is clear: health professional education must integrate both technological literacy and systematic development of horizontal skills. Knowing how an AI tool works is not enough; one must be able to critically evaluate it, explain its limitations, and integrate it responsibly into clinical practice.

In an era where algorithms are becoming increasingly “intelligent,” empathy, responsibility, and critical thinking are not secondary skills—they are the core of a medical practice that seeks to remain human, reliable, and safe.

Ultimately, the question is not whether artificial intelligence will be integrated into medicine—it already has been. The real challenge is under what terms it will coexist with the human factor. As technology advances at geometric speed, education must equally invest in skills that cannot be automated: the ability to listen, to question, and to take responsibility.

The challenge for artificial intelligence in medicine is not only technological but deeply pedagogical and ethical. Perhaps the greatest stake is not to create “smarter” systems but more conscious professionals. As algorithms evolve, so does the need for medicine to remain fundamentally human.

Source
The Growing Importance of Soft Skills in Medical Education in the AI Era, MDPI, 2024.
Available at: https://www.mdpi.com/2813-141X/4/4/50

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Artificial Intelligence (AI) and Remote Patient Monitoring (RPM) are transforming oncology, giving patients a greater role in managing their treatment.

Recent studies have shown that using digital tools to collect medical data outside the traditional clinical setting reduces delayed symptom reporting, limits severe side effects, decreases hospitalizations and emergency visits, while improving survival and quality of life for patients.

In practice, this means digital applications allow patients to promptly inform their doctors of any issues, reducing risks and enhancing their daily experience during treatment.

Based on these findings, in 2022, ESMO published guidelines for integrating patient-reported outcome measures (PROMs) into clinical practice, recommending electronic platforms over paper questionnaires (Ann Oncol. 2022).

Dr. Charles Ferté, Chief Medical & Patient Officer of the Resilience solution, developed in collaboration with the Institut Gustave Roussy in France, highlights that AI can address limitations in using patient reports in oncology. According to him, about 50% of patients’ side effects go unreported, either due to forgotten symptoms or staff workload. Mild but persistent side effects are often overlooked, affecting treatment effectiveness.

The Resilience solution includes an online platform for doctors and nurses to monitor symptoms and receive alerts, and a mobile app for patients to submit real-time data. Data are processed through AI algorithms and transformed into actionable insights for the oncology team, facilitating timely intervention and care optimization. This enables doctors to monitor patients in real time and prevent complications before they become serious.

Additionally, the solution incorporates Natural Language Processing (NLP) to extract data from medical notes and lab results, and a predictive algorithm estimates the risk of severe side effects and unplanned hospitalizations.

Patient engagement is crucial: compliance with weekly questionnaires reaches up to 85%, with many describing the app as a “lifeline” during treatment. Although initially thought to appeal only to younger patients, research shows acceptance spans all ages (JMIR Mhealth Uhealth. 2018; J Geriatr Oncol. 2024).

The solution can also screen large patient populations, identifying those who would benefit from a hybrid care model—digital tools combined with in-person support, such as behavioral and cognitive therapy. Continuous data collection allows RPM to expand to social and behavioral indicators, including isolation, employment, access to care, addictions, physical activity, or food insecurity.

Finally, digital data open new avenues in research: the Resilience database includes over 20,000 patients across 140 hospitals in France, Belgium, Germany, and Spain, enabling real-world data use for more targeted clinical research. In the future, digital phenotyping will allow monitoring of physical and cognitive indicators via mobile sensors like pedometers and gyroscopes, offering a more comprehensive view of the patient experience.

It is clear that cancer care can now rely not only on patient and professional engagement but also on data analysis that uncovers hidden aspects of patients’ daily lives and symptoms.

Kapa3 remains at the forefront of oncology developments, continuously updating on new technologies and practices, actively supporting patients and caregivers, and creating tools and resources that ease daily life. Focused on patient empowerment, Kapa3 bridges scientific knowledge with practical solutions, ensuring everyone feels guided and safe throughout their treatment journey.

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Sources: